ArticleOpen forum infectious diseases2025
Epidemiology of Rubella Virus in a Fragile and Conflict-affected Setting - A Retrospective Analysis of 11 Years Case-based Data in South Sudan.
Article in Open forum infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Introduction: Since establishing routine immunization services in what was then known as Sudan in 1974, South Sudan has not yet introduced the rubella-containing vaccine into its national immunization schedule. This study aims to assess the burden of rubella infection within the existing measles case-based surveillance framework to provide evidence supporting advocacy for introducing the rubella-containing vaccine into the national immunization program. Methods: This study conducted a retrospective descriptive analysis of rubella infection using measles case-based surveillance data from 2013 to 2023. Data were analyzed with descriptive statistics and logistic regression using Epi Info, version 7. Results: During the study period, 17,987 suspected measles cases were reported, with 4944 serum samples collected. Of these, 2083 (42.1%) were positive for measles immunoglobulin M antibodies. Among 2861 samples that tested negative or indeterminate for measles, 678 (23.7%) tested positive for rubella immunoglobulin M antibodies. The study observed a significant increase in rubella positivity rates from 1.6% in 2014 to 34.4% in 2020. Logistic regression analysis showed that rubella infection was significantly more likely among children aged 5-9 years (odds ratio [OR] = 2.234; 95% confidence interval [CI]; 1.468-3.473, Conclusions: The study identified a high prevalence of rubella among young children, particularly those aged 1-9 years and in urban areas, highlighting the need for targeted vaccination strategies. These findings strongly support introducing the rubella vaccine into the national immunization program.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.